AGRX - Agile Therapeutics prices $24M upsized stock offering
- Agile Therapeutics ( NASDAQ: AGRX ) announced Friday the pricing of its $24M upsized public offering that will comprise of 26.67M shares priced at $0.90 each.
- Each share of common stock in the offering is accompanied with Series A-1 warrant, exercisable to purchase second share at $0.90 each.
- The company said it intends to use the net proceeds for working capital, business development activities, and other general corporate purposes.
- Closing of the offering is expected on July 6, 2022.
- Earlier: Agile Therapeutics GAAP EPS of -$3.78 beats by $2.22, revenue of $1.76M beats by $0.54M
For further details see:
Agile Therapeutics prices $24M upsized stock offering